Clinical Trial

SQ-Kyrin TMVr FIM Study

Name: SQ-Kyrin TMVr FIM Study — clinical trial record (NCT05040074)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated September 10, 2021 (before its estimated October 2022 completion). Its status may not reflect the trial's current state.

Summary

A feasibility study to evaluate the effectiveness and safety of the SQ-Kyrin Transcatheter Edge-to-Edge Valve Repair System for the treatment of moderate-to-severe mitral regurgitation in patients with high surgical risk.

Trial Details

NCT Number	NCT05040074
Lead Sponsor	Shanghai Shenqi Medical Technology Co., Ltd
Conditions	Mitral Regurgitation
Enrollment	20 participants
Start Date	2021-04-01
Primary Completion	2022-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2021-09-10